Terug
30
Dagbereik
€ 6,43
€ 6,63
52-Weeksbereik
€ 3,74
€ 8,09
Volume
1.642.016
50D / 200D Gem.
€ 7,01
/
€ 5,87
Vorige Slotkoers
€ 6,40
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 263,4 | 0,4 |
| P/B | 1,7 | 2,9 |
| ROE % | 0,7 | 3,8 |
| Net Margin % | 0,7 | 3,9 |
| Rev Growth 5Y % | 20,9 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 9,30
+42.4%
Low: € 8,00
High: € 11,00
Forward K/W
89,3
Forward WPA
€ 0,07
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,6 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,33
€ 0,22 – € 0,40
|
2,1 B | 4 |
| FY2027 |
€ 0,14
€ 0,13 – € 0,15
|
1,9 B | 4 |
| FY2026 |
€ 0,07
€ 0,06 – € 0,08
|
1,6 B | 4 |
Belangrijkste Punten
Revenue grew 20,86% annually over 5 years — strong growth
ROE of 0,65% is below average
Debt/Equity of 0,13 — conservative balance sheet
Generating 110,03M in free cash flow
P/E of 263,41 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,01%
Groei
Revenue Growth (5Y)
20,86%
Revenue (1Y)13,85%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
0,65%
ROIC1,12%
Net Margin0,68%
Op. Margin1,80%
Veiligheid
Debt / Equity
0,13
Current Ratio1,65
Interest Coverage2,20
Waardering
P/E Ratio
263,41
P/B Ratio1,67
EV/EBITDA96,89
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,85% | Revenue Growth (3Y) | 16,15% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 20,86% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,42B | Net Income (TTM) | 9,66M |
| ROE | 0,65% | ROA | 0,44% |
| Gross Margin | 28,53% | Operating Margin | 1,80% |
| Net Margin | 0,68% | Free Cash Flow (TTM) | 110,03M |
| ROIC | 1,12% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,13 | Current Ratio | 1,65 |
| Interest Coverage | 2,20 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 263,41 | P/B Ratio | 1,67 |
| P/S Ratio | 1,79 | PEG Ratio | -2,34 |
| EV/EBITDA | 96,89 | Dividend Yield | 0,00% |
| Market Cap | 2,55B | Enterprise Value | 2,49B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,42B | 1,25B | 1,06B | 859,54M | 667,51M |
| Net Income | 9,66M | -57,44M | -186,26M | -215,56M | -307,20M |
| EPS (Diluted) | 0,02 | -0,15 | -0,51 | -0,61 | -1,05 |
| Gross Profit | 406,35M | 402,40M | 302,10M | 237,02M | 201,51M |
| Operating Income | 25,71M | -31,61M | -189,13M | -210,17M | -286,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,20B | 2,12B | 2,11B | 2,17B | 1,93B |
| Total Liabilities | 682,92M | 672,01M | 681,04M | 655,15M | 382,08M |
| Shareholders' Equity | 1,52B | 1,45B | 1,43B | 1,52B | 1,55B |
| Total Debt | 194,10M | 485,19M | 511,04M | 478,83M | 158,74M |
| Cash & Equivalents | 248,64M | 154,57M | 78,82M | 108,62M | 148,03M |
| Current Assets | 416,20M | 312,51M | 225,73M | 233,22M | 266,52M |
| Current Liabilities | 251,96M | 228,89M | 202,87M | 176,00M | 116,75M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#809 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026